Clinical Trial: Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer

U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298200) titled 'Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer' on Nov. 26.

Brief Summary: The goal of this clinical trial is to learn the safety of tumor neoantigen vaccine combined with neoantigen vaccine induced T-cell in treating advanced gastric cancer in adults. It will also learn if the combined treatment works to treat advanced gastric cancer.

The main questions it aims to answer are:

What medical problems do participants have when using the combined treatment? Does tumor neoantigen vaccine combined with...